Pericardiocentesis Procedures - Global Market Outlook (2019-2027)

Pericardiocentesis Procedures - Global Market Outlook (2019-2027)

According to Stratistics MRC, the Global Pericardiocentesis Procedures Market is accounted for $144.30 million in 2019 and is expected to reach $230.00 million by 2027 growing at a CAGR of 6.0% during the forecast period. Increase in the geriatric population and high adoption of minimally invasive surgeries for treatment of different medical conditions are the major factors propelling the market growth. However, complications and risk associated with the surgery are hampering the market growth.

Pericardiocentesis is a minimally invasive surgical procedure performed to remove the excess levels of fluid accumulated in the pericardium sac around the heart. The procedure involves the usage of a small needle, which is inserted into the pericardium sac, and a catheter to remove the fluid. Several factors lead to the development of pericardial effusion (excess fluid accumulated in the pericardium). The underlying causes of pericardial effusion are viral, bacterial, and parasitic infections, tuberculosis, breast & lung cancer, end-stage renal diseases, and postoperative cardiac surgery complication. Of the different causes of pericardial effusion, malignancies and cardiovascular diseases are the most common causes, accounting for more than 50% of total pericardial effusion reported cases.

Based on the end-user, the hospital's segment is going to have a lucrative growth during the forecast period owing to the improved treatments of cardiac tamponade across the globe. Well-established surgical infrastructure in hospitals, rise in hospitalization for the underlying causes of cardiac tamponade, and a large number of chemotherapy and radiation therapy treatments in hospitals contributed to the segment’s large share of the global market.

By geography, North America is going to have a lucrative growth during the forecast period due to the high prevalence and increase in the incidence of cancer and cardiovascular diseases in the U.S. and Canada, and well-established healthcare facilities. High per capita healthcare expenditure, favourable medical reimbursement policies, and early adoption of minimally invasive surgeries can be attributed to the region’s large share of the global pericardiocentesis procedures market.

Some of the key players profiled in the Pericardiocentesis Procedures Market include Cleveland Clinic, NewYork-Presbyterian Hospital, The Johns Hopkins Hospital, Saint George Hospital, Buddhist Tzu Chi Medical Foundation, J.W. Goethe University Hospital, The University of Tokyo Hospital, Mediclinic International, Apollo Hospitals Enterprise Ltd, and Florida Hospital Orlando.

Indications Covered:
• Cardiac
• Infections
• Inflammatory/Rheumatology
• Malignancies

End Users Covered:
• Cardiac Centers
• Hospitals

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019 2020, 2024, and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)
• Regional Segmentation
Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances